Tumor Biology (Apr 2017)

Study of the TP53 codon 72 polymorphism in oral cancer and oral potentially malignant disorders in Argentine patients

  • Ana Maria Zarate,
  • Julieta Don,
  • Dante Secchi,
  • Andres Carrica,
  • Fernanda Galindez Costa,
  • Rene Panico,
  • Martin Brusa,
  • José Luis Barra,
  • Mabel Brunotto

DOI
https://doi.org/10.1177/1010428317699113
Journal volume & issue
Vol. 39

Abstract

Read online

The aim of this work was to evaluate the prevalence of TP53Arg72Pro mutations and their possible relationship with oral carcinoma and oral potentially malignant disorders in Argentine patients. A cross-sectional study was performed on 111 exfoliated cytologies from patients with oral cancer (OC), oral potentially malignant disorders (OPMD) and controls. The TP53Arg72Pro mutations were determined using conventional PCR. We evaluated univariate and multivariate study variables, setting p < 0.05. We found: (a) a low frequency of Pro72 variant in control group and a high frequency in OC and OPMD, as well in OC and oral leukoplakia (OL) diagnosis; (b) multivariate association among the TP53CC genotype and females over 45 years with no tobacco nor alcohol habits with oral lichen planus pathology; (c) multivariate association between the TP53GC genotype and males with alcohol and tobacco habits and OC and OL pathologies. Our results showed that the wild-type Arg72variant was related to control patients and Pro72variant was related to OC and OPMD, in Argentine patients.